CRAT
protein-codingcarnitine O-acetyltransferase
Gene summary
This gene encodes carnitine O-acetyltransferase, a member of the carnitine acyltransferase family and a key metabolic pathway enzyme which plays an important role in energy homeostasis and fat metabolism. This enzyme catalyzes the reversible transfer of acyl groups from an acyl-CoA thioester to carnitine and regulates the ratio of acyl-CoA/CoA. It is found in both the mitochondria and the peroxisome. Alternative splicing results in transcript variants encoding different isoforms that may localize to different subcellular compartments. [provided by RefSeq, Oct 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~17.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0054764
Submitter: Ambry Genetics
Inheritance Pattern: Unknown
Disease ID:MONDO:0054764
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CRAT variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000755.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 63 | 6 | 71 | ||
| missense | 1 | 203 | 6 | 3 | 213 | |
| nonsense | 4 | 4 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 1 | 7 | 8 | |||
| splice donor/acceptor (+/-2bp) | 9 | 9 | ||||
| Total | 0 | 2 | 226 | 69 | 9 | 306 |
Highest pathogenic variant AF is 0.000016735012
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000746.3 | 14 | MANE Select | |
| Ensembl | ENSP00000315013.2 | 14 | MANE Select | |
| RefSeq | NP_001244292.2 | 13 | Standard | |
| RefSeq | NP_001333475.2 | 14 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Peroxisome - Homo sapiens (human)
- Beta Oxidation of Very Long Chain Fatty Acids
- Oxidation of Branched Chain Fatty Acids
- Adrenoleukodystrophy, X-linked
- Carnitine-acylcarnitine translocase deficiency
Biological Process
- protein targeting to peroxisome
- carnitine metabolic process, CoA-linked
- fatty acid beta-oxidation using acyl-CoA oxidase
Molecular Function
- carnitine O-acetyltransferase activity
- signaling receptor binding
Cellular Component
- mitochondrion
- mitochondrial inner membrane
- peroxisome
- peroxisomal matrix
- endoplasmic reticulum
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000318080
- Coding exons
- 14
- Length
- 16380
- Individuals with no LoFs
- 125673
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 75
- Defined
- 125748
- p
- 0.000298
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.852 | 354 | 402 | 0.880 | 0.0000260 | 4097 |
| Missense (PolyPhen) | 105 | 133.94 | 0.78395 | 1421 | ||
| Synonymous | 0.578 | 160 | 170 | 0.944 | 0.0000117 | 1225 |
| Loss of Function | 1.59 | 22 | 31.6 | 0.696 | 0.00000160 | 343 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0.00050 | 0.00050 | rare |
| East Asian | 0.00044 | 0.00044 | rare |
| Finnish | 0.000093 | 0.000092 | rare |
| European (Non-Finnish) | 0.00022 | 0.00022 | rare |
| South Asian | 0.00085 | 0.00085 | rare |
| Other | 0.00049 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Catalyzes the reversible transfer of acyl groups from carnitine to coenzyme A (CoA) and regulates the acyl-CoA/CoA ratio. Also plays a crucial role in the transport of fatty acids for beta-oxidation. May be specific for short chain fatty acids. {ECO:0000305|PubMed:29395073}.;
Recessive Scores
- pRec
- 0.509
Intolerance Scores
- LoFtool
- 0.189
- RVIS EVS
- -1.08
- RVIS percentile EVS
- 7.24
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.151
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |